Created in 2006 (Belgium), THROMBOGENICS own 11 sister brands and 2214 competing brands. THROMBOGENICS is owned by ThromboGenics, listed on the stock exchange of Bruxelles The ISIN, the company's International Securities Identification Number, is BE0003846632. The sector of THROMBOGENICS is Biotechnology.

THROMBOGENICS is a brand of ThromboGenics (OXUR) Share price

Share price and profitability of the share ThromboGenics (THROMBOGENICS)

Buy ThromboGenics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.00

Portfolio valuation
ThromboGenics over 5 years* EUR 0.00

Stock market history ThromboGenics (THROMBOGENICS)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more